Notice NOT-AA-17-017 from the NIH Guide for Grants and Contracts

Notice NOT-AA-17-016 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-278 from the NIH Guide for Grants and Contracts. The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this FOA could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, initial development and pilot tests of innovative approaches for intervention, and intervention efficacy trials.

Funding Opportunity PA-18-277 from the NIH Guide for Grants and Contracts. The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this FOA could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, and initial development and pilot tests of innovative approaches for intervention.

Funding Opportunity PA-18-276 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, intervention is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.

Notice NOT-AG-17-022 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-18-190 from the NIH Guide for Grants and Contracts. This FOA encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) as described in NOT-OD-15-137.

Funding Opportunity PAR-18-189 from the NIH Guide for Grants and Contracts. This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) as described in NOT-OD-15-137.

Notice NOT-CA-18-020 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-18-254 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote innovative research that addresses one or both of the following objectives: Devise optimal strategies to improve the identification of persons unaware of their HIV-1 infection and successfully link them to HIV testing, treatment, and prevention interventions. Develop and examine the feasibility and acceptability of novel integrated interventions of biomedical and behavioral strategies that substantially reduce the likelihood of onward HIV transmission in these populations.

Funding Opportunity PAR-18-221 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the discovery and development of medications to treat Cannabis Use Disorders (CUDs) using the UG3/UH3 mechanism. The objective is to advance medications toward the ultimate goal of obtaining FDA approval. Advances in understanding the cannabinoid systems and the effects of marijuana on the brain, coupled with the availability of both novel and marketed medications that may be efficacious to treat these disorders, offer unprecedented opportunities to develop safe and effective pharmacotherapies for CUDs.

Notice NOT-DA-17-056 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-18-217 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NICHD R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.

Notice NOT-CA-18-021 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-059 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-275 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications focused on 1) advancing understanding of mechanisms by which mental health affects HIV prevention and treatment in order to identify modifiable intervention targets; and 2) developing and pilot testing expanded interventions to improve both mental health and HIV outcomes along the entire HIV care continuum (from HIV testing to viral suppression). PA-17-NNN uses the R01 grant mechanism while PA-17-NN uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.

Funding Opportunity PA-18-274 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications focused on 1) advancing understanding of mechanisms by which mental health affects HIV prevention and treatment in order to identify modifiable intervention targets; and 2) developing and testing expanded interventions to improve both mental health and HIV outcomes along the entire HIV care continuum (from HIV testing to viral suppression). PA-17-136 uses the R01 grant mechanism while PA-17-137 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.

Funding Opportunity PA-18-273 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits innovative, targeted basic behavioral and social science and intervention development research to reduce incident HIV infections and improve the health of those living with HIV. This FOA encourages research designed to (a) conduct basic behavioral and social science research that is needed to advance the development of HIV prevention and care interventions, (b) translate and operationalize the findings from these basic studies to develop interventions and assess their acceptability and feasibility and (c) conduct tests of the efficacy of HIV prevention and care interventions. This FOA uses the R01 grant mechanism while PA-18-272 uses the R21 mechanism.

Funding Opportunity PA-18-272 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages innovative, targeted basic behavioral and social science and intervention development research to reduce incident HIV infections and improve the health of those living with HIV. This FOA encourages research designed to (a) conduct basic behavioral and social science research that is needed to advance the development of HIV prevention and care interventions, (b) translate and operationalize the findings from these basic studies to develop interventions and assess their acceptability and feasibility and (c) conduct tests of the efficacy of HIV prevention and care interventions. PA-17-106 uses the R01 grant mechanism while this FOA uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.

Funding Opportunity PA-18-271 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages behavioral, social, and implementation science research designed to (a) identify gaps in the HIV pre-exposure prophylaxis (PrEP) care continuum and associated determinants; (b) develop and test interventions to strengthen PrEP delivery, use, and outcomes; and (c) reduce racial/ethnic and age-related disparities in PrEP uptake and use.